What does CENTRE DE CARDIOLOGIE M. LEMPEREUR do?

CENTRE DE CARDIOLOGIE M. LEMPEREUR is a specialist medical practice in Liège. Private Limited, started on 20 November 2018, 1 establishment.

What is the address of CENTRE DE CARDIOLOGIE M. LEMPEREUR?

The registered office of CENTRE DE CARDIOLOGIE M. LEMPEREUR is located at Rue Hubble 30, 4031 Liège.

Is CENTRE DE CARDIOLOGIE M. LEMPEREUR still active?

Yes. According to the CBE (3 October 2026) CENTRE DE CARDIOLOGIE M. LEMPEREUR is active, legal situation “Normale toestand”, started on 20 November 2018.

Is CENTRE DE CARDIOLOGIE M. LEMPEREUR registered on Peppol?

Yes, CENTRE DE CARDIOLOGIE M. LEMPEREUR is registered on the Peppol network with ID 0208:0713727879.

What is the enterprise number of CENTRE DE CARDIOLOGIE M. LEMPEREUR?

The enterprise number of CENTRE DE CARDIOLOGIE M. LEMPEREUR is BE0713727879.

When was CENTRE DE CARDIOLOGIE M. LEMPEREUR founded?

CENTRE DE CARDIOLOGIE M. LEMPEREUR was founded on 20 November 2018.

Who are the directors of CENTRE DE CARDIOLOGIE M. LEMPEREUR?

According to the 2025 annual accounts, the directors of CENTRE DE CARDIOLOGIE M. LEMPEREUR are: Mathieu Lempereur.

Is CENTRE DE CARDIOLOGIE M. LEMPEREUR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 November 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CENTRE DE CARDIOLOGIE M. LEMPEREUR make in 2025?

CENTRE DE CARDIOLOGIE M. LEMPEREUR posted a profit after taxes of € 95,233 in financial year 2025.

What is the revenue of CENTRE DE CARDIOLOGIE M. LEMPEREUR?

As a small company, CENTRE DE CARDIOLOGIE M. LEMPEREUR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 144,049.

CENTRE DE CARDIOLOGIE M. LEMPEREUR (Private Limited)

Dossier CENTRE DE CARDIOLOGIE M. LEMPEREUR, printed on 3 October 2026 from databakkes.be/en/0713727879/centre-de-cardiologie-m-lempereur. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

CENTRE DE CARDIOLOGIE M. LEMPEREUR from Liège, company number BE0713727879, closed financial year 2025 with a result of € 95,233 after tax. For that financial year CENTRE DE CARDIOLOGIE M. LEMPEREUR recorded a gross margin of € 144,049 and equity of € 98,740. Compared with financial year 2024, the result moved from € 78,005 to € 95,233. Profitable, and profit is growing. The buffer shrank hard: equity is 54 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Shrank hard

€ 98,740

▼ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 95,233

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 108,126

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 210,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,403

▼ 60% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,686

▲ 139% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 12,532

▲ 18% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 84,976 Gross margin 2022: € 84,976 First fiscal year in the series	€ 115,448 Gross margin 2023: € 115,448 ▲ 36% vs 2022 (€ 84,976) Favourable step	€ 124,669 Gross margin 2024: € 124,669 ▲ 8% vs 2023 (€ 115,448) Favourable step	€ 144,049 Gross margin 2025: € 144,049 ▲ 16% vs 2024 (€ 124,669) Favourable step	▲ 16%
Profit after taxes	€ 47,154 Profit after taxes 2022: € 47,154 First fiscal year in the series	€ 69,856 Profit after taxes 2023: € 69,856 ▲ 48% vs 2022 (€ 47,154) Favourable step	€ 78,005 Profit after taxes 2024: € 78,005 ▲ 12% vs 2023 (€ 69,856) Favourable step	€ 95,233 Profit after taxes 2025: € 95,233 ▲ 22% vs 2024 (€ 78,005) Favourable step	▲ 22%
Equity	€ 216,945 Equity 2022: € 216,945 First fiscal year in the series	€ 186,801 Equity 2023: € 186,801 ▼ 14% vs 2022 (€ 216,945) Unfavourable step	€ 213,507 Equity 2024: € 213,507 ▲ 14% vs 2023 (€ 186,801) Favourable step	€ 98,740 Equity 2025: € 98,740 ▼ 54% vs 2024 (€ 213,507) Unfavourable step	▼ 54%
Total debts	€ 19,921 Total debts 2022: € 19,921 First fiscal year in the series	€ 113,238 Total debts 2023: € 113,238 ▲ € 93,317 vs 2022 (€ 19,921) Unfavourable step	€ 72,656 Total debts 2024: € 72,656 ▼ 36% vs 2023 (€ 113,238) Favourable step	€ 224,348 Total debts 2025: € 224,348 ▲ 209% vs 2024 (€ 72,656) Unfavourable step	▲ 209%
Cash	€ 108,396 Cash 2022: € 108,396 First fiscal year in the series	€ 186,670 Cash 2023: € 186,670 ▲ 72% vs 2022 (€ 108,396) Favourable step	€ 167,190 Cash 2024: € 167,190 ▼ 10% vs 2023 (€ 186,670) Unfavourable step	€ 108,126 Cash 2025: € 108,126 ▼ 35% vs 2024 (€ 167,190) Unfavourable step	▼ 35%
Retained profit	€ 198,345 Retained profit 2022: € 198,345 First fiscal year in the series	€ 168,201 Retained profit 2023: € 168,201 ▼ 15% vs 2022 (€ 198,345) Unfavourable step	€ 194,907 Retained profit 2024: € 194,907 ▲ 16% vs 2023 (€ 168,201) Favourable step	€ 80,140 Retained profit 2025: € 80,140 ▼ 59% vs 2024 (€ 194,907) Unfavourable step	▼ 59%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▲ € 99,200 vs 2022 (€ 800) Unchanged	€ 51,300 Dividend 2024: € 51,300 ▼ 49% vs 2023 (€ 100,000) Unchanged	€ 210,000 Dividend 2025: € 210,000 ▲ € 158,700 vs 2024 (€ 51,300) Unchanged	▲ € 158,700
Balance sheet total	€ 236,866 Balance sheet total 2022: € 236,866 First fiscal year in the series	€ 300,039 Balance sheet total 2023: € 300,039 ▲ 27% vs 2022 (€ 236,866) Unchanged	€ 286,162 Balance sheet total 2024: € 286,162 ▼ 5% vs 2023 (€ 300,039) Unchanged	€ 323,088 Balance sheet total 2025: € 323,088 ▲ 13% vs 2024 (€ 286,162) Unchanged	▲ 13%

Key figures of CENTRE DE CARDIOLOGIE M. LEMPEREUR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CENTRE DE CARDIOLOGIE M. LEMPEREUR?

What happened at CENTRE DE CARDIOLOGIE M. LEMPEREUR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 95,233 (▲ 22% vs 2024). filed late Source: NBB ↗
Nov 20, 2018 New establishment in Liège. KBO
Nov 20, 2018 Start of the company according to the CBE. KBO

In short

From € 47,154 profit in 2022 to € 95,233 profit in 2025.

Paid € 103,953 in corporate taxes since 2022.

Best year ever: 2025, with € 95,233 profit.

Paid out € 362,100 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CENTRE DE CARDIOLOGIE M. LEMPEREUR? We notify you, reason included.

Follow CENTRE DE CARDIOLOGIE M. LEMPEREUR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mathieu Lempereur

CENTRE DE CARDIOLOGIE M. LEMPEREUR

Behind CENTRE DE CARDIOLOGIE M. LEMPEREUR is Mathieu Lempereur.

See the full network in the app

Directors

According to the 2025 annual accounts

Mathieu Lempereur

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Hubble 30

4031 Liège

2.282.836.897

Rue Laurent-de-Koninck 3

4000 Liège

Active since 20 November 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0713.727.879
VAT number: BE 0713.727.879
Registered office: Rue Hubble 30, 4031 Liège
Names & denominations: CENTRE DE CARDIOLOGIE M. LEMPEREUR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 November 2018
Peppol: Active · Active since 8 Dec 2025
Contact: [email protected] +32474478404
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗